Skip to main content
Report this ad

See also:

BMS drug plus Gilead drug shows highest cure rates for hepatitis C

An experimental drug daclatasvir from Bristol-Myers Squibb plus an existing drug called Sovaldi yields best-ever cure rates for hepatitis C.
An experimental drug daclatasvir from Bristol-Myers Squibb plus an existing drug called Sovaldi yields best-ever cure rates for hepatitis C.
Photo by @Doug88888 / Creative Commons
Report this ad